Utah Medical Products ROE 2006-2020 | UTMD

Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Utah Medical Products ROE for the three months ending March 31, 2020 was 14.72%.
Utah Medical Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.02B $0.09B 15.63%
2019-12-31 $0.02B $0.10B 15.71%
2019-09-30 $0.01B $0.10B 15.14%
2019-06-30 $0.02B $0.09B 18.68%
2019-03-31 $0.02B $0.09B 19.26%
2018-12-31 $0.02B $0.09B 20.93%
2018-09-30 $0.01B $0.09B 14.41%
2018-06-30 $0.01B $0.08B 11.08%
2018-03-31 $0.01B $0.08B 11.29%
2017-12-31 $0.01B $0.08B 11.65%
2017-09-30 $0.02B $0.08B 20.00%
2017-06-30 $0.01B $0.08B 19.18%
2017-03-31 $0.01B $0.07B 18.18%
2016-12-31 $0.01B $0.07B 16.84%
2016-09-30 $0.01B $0.07B 16.78%
2016-06-30 $0.01B $0.07B 17.08%
2016-03-31 $0.01B $0.07B 17.27%
2015-12-31 $0.01B $0.07B 17.78%
2015-09-30 $0.01B $0.07B 18.11%
2015-06-30 $0.01B $0.07B 18.39%
2015-03-31 $0.01B $0.06B 18.60%
2014-12-31 $0.01B $0.07B 18.68%
2014-09-30 $0.01B $0.06B 18.97%
2014-06-30 $0.01B $0.07B 19.51%
2014-03-31 $0.01B $0.06B 20.51%
2013-12-31 $0.01B $0.06B 21.62%
2013-09-30 $0.01B $0.06B 20.75%
2013-06-30 $0.01B $0.05B 21.57%
2013-03-31 $0.01B $0.05B 20.30%
2012-12-31 $0.01B $0.05B 20.94%
2012-09-30 $0.01B $0.05B 22.10%
2012-06-30 $0.01B $0.05B 20.93%
2012-03-31 $0.01B $0.05B 21.69%
2011-12-31 $0.01B $0.04B 17.61%
2011-09-30 $0.01B $0.04B 17.95%
2011-06-30 $0.01B $0.04B 17.95%
2011-03-31 $0.01B $0.04B 15.48%
2010-12-31 $0.01B $0.04B 17.95%
2010-09-30 $0.01B $0.04B 17.95%
2010-06-30 $0.01B $0.04B 18.30%
2010-03-31 $0.01B $0.04B 21.33%
2009-12-31 $0.01B $0.04B 21.92%
2009-09-30 $0.01B $0.04B 22.38%
2009-06-30 $0.01B $0.04B 21.92%
2009-03-31 $0.01B $0.04B 21.33%
2008-12-31 $0.01B $0.04B 20.78%
2008-09-30 $0.01B $0.04B 20.25%
2008-06-30 $0.01B $0.04B 20.51%
2008-03-31 $0.01B $0.04B 20.92%
2007-12-31 $0.01B $0.04B 21.19%
2007-09-30 $0.01B $0.04B 21.62%
2007-06-30 $0.01B $0.04B 22.07%
2007-03-31 $0.01B $0.04B 22.54%
2006-12-31 $0.01B $0.04B 23.02%
2006-09-30 $0.01B $0.04B 23.53%
2006-06-30 $0.01B $0.03B 23.70%
2006-03-31 $0.01B $0.03B 23.70%
2005-12-31 $0.01B $0.03B 23.36%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.313B $0.047B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.760B 28.40
Medtronic (MDT) Ireland $122.876B 19.96
Stryker (SYK) United States $68.133B 22.11
Boston Scientific (BSX) United States $48.348B 22.73
Baxter (BAX) United States $42.697B 26.06
Lonza Group Ag (LZAGY) Switzerland $42.097B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.300B 0.00
Terumo (TRUMY) Japan $28.368B 36.26
ResMed (RMD) United States $27.881B 44.00
Zimmer Biomet Holdings (ZBH) United States $24.546B 15.44
Sunny Optical Technology (SNPTF) China $20.292B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.095B 0.00
Bio-Rad Laboratories (BIO) United States $13.860B 63.09
Insulet (PODD) United States $13.102B 1298.06
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.974B 78.38
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.628B 38.88
Perrigo (PRGO) Ireland $7.488B 13.40
Hill-Rom Holdings (HRC) United States $7.452B 21.01
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.729B 0.00
Haemonetics (HAE) United States $4.502B 27.04
Neogen (NEOG) United States $4.099B 69.43
GW Pharmaceuticals (GWPH) United Kingdom $4.005B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.905B 0.00
ICU Medical (ICUI) United States $3.833B 27.96
Agios Pharmaceuticals (AGIO) United States $3.779B 0.00
Envista Holdings (NVST) United States $3.229B 0.00
NuVasive (NUVA) United States $2.788B 22.39
TG Therapeutics (TGTX) United States $2.629B 0.00
National Vision Holdings (EYE) United States $2.369B 40.99
AtriCure (ATRC) United States $1.744B 0.00
MacroGenics (MGNX) United States $1.548B 0.00
NanoString Technologies (NSTG) United States $1.417B 0.00
Aurora Cannabis (ACB) Canada $1.377B 0.00
Aphria (APHA) Canada $1.233B 0.00
Cerus (CERS) United States $1.159B 0.00
Cardiovascular Systems (CSII) United States $1.072B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.48
Phibro Animal Health (PAHC) United States $1.015B 20.24
Vapotherm (VAPO) United States $0.971B 0.00
PetIQ (PETQ) United States $0.948B 27.39
DFB Healthcare Acquisitions (AHCO) United States $0.919B 153.00
InMode (INMD) Israel $0.916B 19.36
Zynex (ZYXI) United States $0.875B 87.87
OraSure Technologies (OSUR) United States $0.830B 167.13
Quanterix (QTRX) United States $0.762B 0.00
Omeros (OMER) United States $0.757B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.634B 45.44
VAREX IMAGING (VREX) United States $0.580B 14.40
BioLife Solutions (BLFS) United States $0.574B 163.54
Lantheus Holdings (LNTH) United States $0.572B 11.50
Surmodics (SRDX) United States $0.571B 68.79
LeMaitre Vascular (LMAT) United States $0.528B 30.09
Owens & Minor (OMI) United States $0.486B 12.85
Viemed Healthcare (VMD) United States $0.406B 36.00
Cytosorbents (CTSO) United States $0.369B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.335B 0.00
HEXO (HEXO) $0.309B 0.00
Organigram Holdings (OGI) Canada $0.271B 0.00
InfuSystems Holdings (INFU) United States $0.223B 123.67
Female Health (VERU) United States $0.217B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Surface Oncology (SURF) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.164B 0.00
Exagen (XGN) United States $0.145B 0.00
Fonar (FONR) United States $0.136B 12.03
Rockwell Medical (RMTI) United States $0.127B 0.00
United Health Products (UEEC) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Evolus (EOLS) United States $0.113B 0.00
Wound Management Technologies (SMTI) United States $0.105B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.31
Trinity Biotech (TRIB) Ireland $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00